Company profile for Alto Neuroscience

Alto Neuroscience

NEW Drugs in Dev: 8

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

Contact Supplier

Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

pharmacompass-2-m-2026-04-20

Contact Supplier

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

86 News #PharmaBuzz

media
86 News #PharmaBuzz

DEVELOPMENTS

33 Drugs in Development

33 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

To bring every person suffering from a mental health condition the right treatment for them, right away. Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through our AI-enabled biomarker platform, we combine rich sources of information on patients’ brain activity and behavior to rapid...

To bring every person suffering from a mental health condition the right treatment for them, right away. Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through our AI-enabled biomarker platform, we combine rich sources of information on patients’ brain activity and behavior to rapidly develop highly-effective medicines for targeted populations. We aim to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient

PEGS Boston SummitPEGS Boston Summit

Not Confirmed

Not Confirmed

11 May-15 November, 2026

Massachusetts, U.S.A
DIA Global Annual Meet...DIA Global Annual Meeting

Not Confirmed

Not Confirmed

14-18 June, 2026

Philadelphia, U.S.A
Discovery EuropeDiscovery Europe

Not Confirmed

Not Confirmed

15-16 June, 2026

Berlin, Germany

CONTACT DETAILS

Click the arrow to open the dropdown

United_States_of_America Flag

Country

Country

U.S.A

Address

Address

369 South San Antonio Road Los Altos, CA 94022

Telephone

Telephone

Email

enquiries@pharmacompass.com

Client Website

Website

https://www.altoneuroscience.com/

Linkedin

https://www.linkedin.com/company/altoneuroscience/

youtube

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Alto Neuroscience Appoints Andrew Miller to Board

28 May 2026

// BUSINESSWIRE

Alto Neuroscience CEO Amit Etkin Wins Columbia Research Award

15 May 2026

// BUSINESSWIRE

Alto Neuroscience Reports Q1 2026 Results and Business Highlights

13 May 2026

// BUSINESSWIRE

Alto Neuroscience Presents Phase 2a ALTO-207 Data in MDD at SOBP

04 May 2026

// BUSINESSWIRE

Alto Neuroscience Starts Phase 2b Trial for Resistant Depression

21 Apr 2026

// BUSINESSWIRE

Alto Halts Work On PDE4 Inhibitor After Ph. 2 Schizophrenia Fail

02 Apr 2026

// FIERCE BIOTECH

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Market Place

Home

Menu

Post Enquiry

Market Place

Search